Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profile of embryonic and endometrial cells at postimplantation stage ex vivo to assess the effect of a selective COX-2 inhibitor celecoxib.

ABSTRACT: We have newly established a novel ex vivo implantation system. To verify the ex vivo embryonic and endometrial gene expression profile, we performed RNA-sequencing (RNA-seq).

ORGANISM(S): Mus musculus

PROVIDER: GSE279268 | GEO | 2025/05/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression profile at single cell level of endometrial cells at postimplantation stage both in vivo and ex vivo.

Project description:We have newly established a novel ex vivo implantation system. To verify the ex vivo endometrial gene expression profile in comparison with in vivo, we performed single cell RNA-sequencing (scRNA-seq).

2025-05-05 | GSE279809 | GEO

Gene expression profile of embryonic and endometrial cells at postimplantation stage ex vivo to assess the effect of a selective COX-2 inhibitor celecoxib.

Project description:Gene expression profile of embryonic and endometrial cells at postimplantation stage ex vivo to assess the effect of a selective COX-2 inhibitor celecoxib.

| PRJNA1171772 | ENA

Gene expression profile at single cell level of embryonic cells at postimplantation stage both in vivo and ex vivo.

Project description:We have newly established a novel ex vivo implantation system. To verify the ex vivo postimplantation embyonic gene expression profile in comparison with in vivo, we performed single cell RNA-sequencing (scRNA-seq).

2025-05-05 | GSE279808 | GEO

Gene expression profile at single cell level of endometrial cells at postimplantation stage both in vivo and ex vivo.

Project description:Gene expression profile at single cell level of endometrial cells at postimplantation stage both in vivo and ex vivo.

| PRJNA1174720 | ENA

AM in vivo and ex vivo RNAseq

Project description:AM in vivo and ex vivo RNAseq

| PRJNA799312 | ENA

Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal Cancer

Project description:Prospective, open labelled, multicenter trial to evaluate the feasibility of ex vivo culture 3D (chemogram obtaining) on biopsies in order to estimate the predictive value of this technique for treatment response in patients treated by two different chemotherapies (FOLFOX or FOLFIRI) for colorectal cancer.

| 2221037 | ecrin-mdr-crc

Epigenetic Memory of AM in vivo and ex vivo

Project description:Epigenetic Memory of AM in vivo and ex vivo

| PRJNA799313 | ENA

RNA-seq of ex vivo primate cells

Project description:RNA-seq of ex vivo primate cells

| PRJEB43706 | ENA

Epidermal gene expression in wound healing and after ex vivo injury

Project description:Human in vivo skin wound: Non-wounded skin was obtained by taking punch biopsies from three healthy donors (donor 1,2 and 3). The samples were termed 'skin day 0 in vivo wound'. Skin wound samples were retrieved by making new punch biopsies from the edge of the original biopsies after four days. These samples were termed 'skin day 4 in vivo wound'. As much dermal tissue as possible was removed by dissection to make sure mainly epidermis was present in the samples. The samples were washed in NaCl to possible remove infiltrating inflammatory cells before RNA isolation. Ex vivo skin wounds: Skin was obtained from three healthy donors following reduction surgery (donor 1, 2, and 3). As much dermal tissue as possible was removed dissection. These samples were termed 'skin day 0 ex vivo wound'. Skin was sliced into 1x10 mm slices and incubated in keratinocyte medium for four days with either 1:1000 fold dilution of DMSO or 10 micromolar AG-1478 (dissolved in DMSO). Again as much dermal tissue was removed by dissection as possible before RNA was isolated. These samples were termed 'skin day 4 ex vivo wound' and 'skin day 4 AG-1478 ex vivo wound'. By comparing the gene expression day 4 in ex vivo wound with in vivo wounds it was possible to see which part of the gene expression in wounded skin that was due to the epidermal reaction to injury and how much was due to stimuli from infiltrating inflammatory cells absent in the ex vivo skin wounds. By comparing the data from ex vivo skin wounds day 4 with and without the EGFR-inhibitor AG-1478, it was possible to look at the importance of the EGF-receptor of EGFR for the gene expression in ex vivo wounded skin.

2011-09-13 | E-MEXP-3305 | biostudies-arrayexpress

MicroRNA profiling of human AGS gastric cancer cell line was treated with the selective COX-2 inhibitor celecoxib

Project description:AGS gastric cancer cell line was treated with the selective COX-2 inhibitor celecoxib. microRNA expression profile was analyzed between untreated cells and cells treated with celecoxib.

2009-07-11 | E-MEXP-2231 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data